The invention is in the field of treatment of respiratory diseases using a gamma secretase inhibitor. In particular, it relates to the treatment of cystic fibrosis (CF), primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease (COPD), asthma or respiratory tract infections using a gamma secretase inhibitor.